Osteolytic lesion in chronic myelogenous leukaemia.
Destructive bone lesion of the femur was observed in one patient from a series of 103 patients with CML. Numerous myeloblasts were seen on touch preparations of the fresh surgical specimen obtained by open biopsy of the affected area. Bone marrow and peripheral blood differential count were compatible with chronic phase of CML at this time. 5 months later blastic crisis developed. Local radiotherapy produced effective palliation of pain but did not prevent blastic transformation of CML. The treatment of blastic crisis was unsuccessful and patient died 3 years after diagnosis of CML, 6 months after the first clinical evidence of bone infiltration.
D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001862:Bone Resorption / Q000000981:diagnostic imaging*; D003131:Combined Modality Therapy; D005266:Femoral Neoplasms / Q000000981:diagnostic imaging* / Q000188:drug therapy; D006801:Humans; D007951:Leukemia, Myeloid / Q000000981:diagnostic imaging* / Q000188:drug therapy; D008297:Male; D010014:Osteolysis / Q000000981:diagnostic imaging*; D011379:Prognosis; D011859:Radiography; D011879:Radiotherapy Dosage